Summary
Updated Aug 30, 2026
Margaret G. McGlynn is Director of NOVAVAX INC (NVAX). 5 SEC Form 4 filings on record going back to 2025, most recently on 23 June 2026.
Recent Transactions
4Every recent SEC Form 4 transaction Margaret G. McGlynn has reported, most recent first.
Other Insiders Active in the Same Sector
No other insider has filed at Margaret G. McGlynn's companies, so these are insiders reporting open-market trades at other companies in the same sector.
- Daniel Patrick O'Day - $47.86M of GILD open-market activity in the last 12 months
- Roger Adsett - $47.51M of INSM open-market activity in the last 12 months
- Bihua Chen - $46.87M of MLTX open-market activity in the last 12 months
- Mario Schlosser - $46.37M of OSCR open-market activity in the last 12 months
- Matthew Gline - $46.22M of ROIV open-market activity in the last 12 months
- Larry Robbins - $46.04M of BFLY open-market activity in the last 12 months
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
Who is Margaret G. McGlynn?
Margaret G. McGlynn is a corporate insider, tracked as Director of NOVAVAX INC (NVAX). InsiderAlpha holds 5 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Margaret G. McGlynn submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
Where can I see all of Margaret G. McGlynn's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Follow Margaret G. McGlynn and every insider like them
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial
